Caprotec Bioanalytics

NEW YORK (GenomeWeb News) – Berlin-based biotech-firm Caprotec Bioanalytics said today that it has entered a research agreement with Syngenta to profile the interactions of one of Syngenta's active compounds with the proteome of certain relevant plant systems.

NEW YORK (GenomeWeb News) – Berlin-based biotech-firm Caprotec Bioanalytics said today that it has entered a research collaboration with Bayer CropScience to identify and study an agrochemical target.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Caprotec Bioanalytics has reached an agreement to use its technology to screen an undisclosed new active ingredient from Bayer CropScience.

Movers & Shakers

Premium

Marc Voigt, Lars Rebien Sorensen, Robert McBurney

According to CEO Hubert Koster, the financing will allow the company to expand its Capture Compound Mass Spectrometry technology into additional markets and "execute several large pharma partnerships at the same time."

Movers & Shakers

Premium

Arthur Moseley, David Lemus, Rainer Metternich, William Curry

This round of financing will allow the company to move into new markets and pursue partnerships with pharmaceutical firms.

The technology, which enables the isolation of functionally selected proteins from complex biological samples, has demonstrated potential usefulness in studying drug-protein interactions and could increase the efficiency of the drug development process.

Proceeds from the private financing will be used to further develop its Capture Compound Mass Spectrometry technology for analyzing complex protein mixtures.

New Products

Premium

Thermo Fisher Scientific, Caprotec Bioanalytics

Pages

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.